Research study Program year 2025 Source: CMS Open Payments

Phase 1 Astrocytoma study which is a study looking at the combination of Vorasidenib and Pembrolizumab

Research payments

$16,083,601

1,435 payments

Through program year 2025, $16,083,601 in research payments was reported against Phase 1 Astrocytoma study which is a study looking at the combination of Vorasidenib and Pembrolizumab, across 1,435 payments, paid by Servier BioInnovation.

Paid by: Servier BioInnovation
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$1,811,557	663
2024	Research	$12,677,072	485
2023	Research	$1,594,973	287

Breakdown

Who paid Research payments · program years 2023–2025

Servier BioInnovation $16,083,601 1,435 payments

Who received the money Research payments · program years 2023–2025

University Of Miami Organisation paid for research $2,347,168 197 payments
Northwestern University Organisation paid for research $1,837,113 155 payments
Ut Md Anderson Cancer Center Teaching hospital · TX $1,397,304 113 payments
Duke University Medical Center Organisation paid for research $1,304,072 25 payments
Cleveland Clinic Hospital Teaching hospital · OH $1,119,805 112 payments
Memorial Sloan Kettering Cancer Center Organisation paid for research $1,082,742 86 payments
University of California, San Francisco Organisation paid for research $812,143 13 payments
Johns Hopkins University Organisation paid for research $680,221 38 payments
Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $678,507 35 payments
University Of Alabama Hospital Teaching hospital · AL $634,897 49 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.